Literature DB >> 10051452

Amyloid precursor protein metabolism in fibroblasts from individuals with one, two or three copies of the amyloid precursor protein (APP) gene.

M Racchi1, J A Johnston, F M Flood, R F Cowburn, S Govoni.   

Abstract

Protein kinase C (PKC)-activated modulation of amyloid precursor protein (APP) metabolism has been investigated in natural models of altered APP expression due to the presence of one, two or three copies of the APP gene. We show that levels of APP present in human skin fibroblasts strongly influence the effect of PKC activation of soluble APP (sAPP) release. Thus fibroblasts derived from a patient with a deletion in chromosome 21 including the APP locus (Delta21) had lower levels of both APP mRNA and cell-associated APP, and showed an exaggerated phorbol-ester-induced sAPP release, when compared with fibroblasts from control individuals. In contrast, fibroblasts from chromosome 21 trisomic Down's syndrome patients failed to show a concentration-dependent response to phorbol ester treatment. These results suggest that the levels of APP expression can affect the degree of response to PKC-mediated modulation of the metabolism of this protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051452      PMCID: PMC1220116     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

Review 1.  Amyloid beta-protein and the genetics of Alzheimer's disease.

Authors:  D J Selkoe
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

2.  Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content.

Authors:  M Racchi; R Baetta; N Salvietti; P Ianna; G Franceschini; R Paoletti; R Fumagalli; S Govoni; M Trabucchi; M Soma
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

3.  Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.

Authors:  H Godridge; G P Reynolds; C Czudek; N A Calcutt; M Benton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

4.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Authors:  J Kang; H G Lemaire; A Unterbeck; J M Salbaum; C L Masters; K H Grzeschik; G Multhaup; K Beyreuther; B Müller-Hill
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

5.  Normal superoxide dismutase-1 (SOD-1) activity with deletion of chromosome band 21q21 supports localization of SOD-1 locus to 21q22.

Authors:  E A Wulfsberg; R E Carrel; I J Klisak; T J O'Brien; J A Sykes; R S Sparkes
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Alzheimer's disease in Down's syndrome: clinicopathologic studies.

Authors:  K E Wisniewski; A J Dalton; C McLachlan; G Y Wen; H M Wisniewski
Journal:  Neurology       Date:  1985-07       Impact factor: 9.910

7.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

Authors:  K E Wisniewski; H M Wisniewski; G Y Wen
Journal:  Ann Neurol       Date:  1985-03       Impact factor: 10.422

8.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.

Authors:  R E Tanzi; A I McClatchey; E D Lamperti; L Villa-Komaroff; J F Gusella; R L Neve
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

9.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Authors:  P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; B Greenberg; K Davis; W Wallace; I Lieberburg; F Fuller
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

10.  The topography of plaques and tangles in Down's syndrome patients of different ages.

Authors:  D M Mann; P O Yates; B Marcyniuk; C R Ravindra
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Sep-Oct       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.